Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    18718815 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Pre-operative Zoledronate in Triple Negative Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Zoledronate
2 Active, not recruiting Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
Condition: Breast Cancer
Interventions: Drug: tamoxifen;   Drug: anastrozole;   Drug: zoledronic acid

Indicates status has not been verified in more than two years